Client News Posts Articles

In this section, we are proud to present recent real-world evidence initiatives and accomplishments of our Clients.  We also post our own observations, as well as more detailed Articles, which we hope you will find useful.  Our Articles may also be found in our KnowledgeBase.

Use the search bar to quickly find a Latest item of interest to you by any keyword.  Alternatively, feel free to use the slider arrows to scroll through each section; you never know when you may find something relevant.

RegenMed January 2023 Newsletter – Client Activities

In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.
January 24, 2023

Comparing Long-Term Outcomes Across Varying Grades of Knee Osteoarthritis – A Real-World Cohort Study

Millions of patients each year are affected by knee osteoarthritis. The severity of this condition is often categorized using the Kellgren-Lawrence (KL) scale, which uses the numbers 0 through 4 to represent the absence or varying grades of symptom presentation. Patients with long-term and/or severe symptoms are often indicated for surgery, while patients with minimal symptoms can employ simpler tools, such as NSAIDS.
November 1, 2022

Gulf Coast Biologics To Support Members-Only Data Registries with RegenMed

Gulf Coast Biologics Training and Education Center, Fort Myers FL, headed by Peter Everts, Ph.D., FRSM, is dedicated to providing the latest advancements in autologous regenerative medicine treatment options to physicians, practitioners, and health care providers across the globe. Many of those advances are increasingly dependent upon capturing and analyzing the large amounts of real-world data generated by everyday clinical cases.
October 24, 2022

Correlating PRP Dosage to Outcomes in Québec, Canada

It’s been two years since Health Canada released a position paper clarifying their regulations on autologous cell therapy products. Among their key requirements were redefining that “the process is the product” and that “products with proper process controls” could increase the probability that “products would be consistent in strength, quality and purity”. Thus, autologous cell therapies are “drugs” and are subject to the specific provisions for drugs under the Act.
September 28, 2022

Canine Survivability by Breed: Ardent’s K9-ACV Registry

Ardent Animal Health (Lexington, KY) and researchers from the University of Kentucky Markey Cancer Center have developed a customized cancer treatment for dogs, known as K9-ACV1. The aim of this vaccine is to trigger the canine patients’ immune system to identify the cancer as a foreign invader. The safety and efficacy of this vaccine are not yet formally established, and these treatments are delivered under 9 CFR 103.3 via USDA Center for Veterinary Biologics oversight, and through supervision/prescription of a licensed veterinarian.
September 22, 2022

Posts

Articles

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

January 27, 2023

RegenMed January 2023 Newsletter – Client Activities

November 1, 2022

Comparing Long-Term Outcomes Across Varying Grades of Knee Osteoarthritis – A Real-World Cohort Study

October 24, 2022

Gulf Coast Biologics To Support Members-Only Data Registries with RegenMed

September 28, 2022

Correlating PRP Dosage to Outcomes in Québec, Canada

September 22, 2022

Canine Survivability by Breed: Ardent’s K9-ACV Registry

September 8, 2022

MSCs for Knee Osteoarthritis: Bioxcellerator’s Ongoing Real World Study

April 4, 2022

RegenMed and MDBiologix to Advance Safe, Efficacious and Regulatorily-Compliant Regenerative Medicine Therapies in Canada

February 1, 2022

REAL-WORLD DATA: OWNERSHIP, CONTROL AND GENERATING VALUE

December 30, 2021

Supporting Healthcare Practitioners, Collaboration and Evidence

December 20, 2021

Ardent Animal Health, LLC Prepares Circles for Leading Animal Clinical Registry in 2022

December 7, 2021

First State Spine Uses Circles for Reimbursement

November 10, 2021

Opinion: American Medical Society for Sports Medicine Position

November 2, 2021

Plasmaconcept AG Prepares Circles for 2022 Post-Market Surveillance Strategy

October 28, 2021

The Role of Real-World Evidence in Medical Product Distribution

October 26, 2021

The Rising Role of Real-World Data and Real-World Evidence in Healthcare

October 6, 2021

Circles Chosen for Stem Cell-Enriched Lipofilling Patient Registry in Europe

September 7, 2021

Introducing Regenerative Medicine Services of France

July 28, 2021

Multinational Comparison of SVF, PRP and BMAC in MSK

July 14, 2021

PRP vs. Adipose in Knee OA, Argentina

June 30, 2021

CELLS Webinar: Intraosseous PRP for Knee OA

June 23, 2021

BMA in Sports Medicine: An Evidence-based Approach in NYC

June 16, 2021

New Webinar Series: PRP & BMAC

June 9, 2021

Improving Patient Engagement through Competition

May 19, 2021

Hyaluronic Acid v. HA+Autologous PRP For Knee OA

May 12, 2021

StemMedical’s Regenerative Aesthetics Registry

May 5, 2021

Kenneth R. Zaslav, M.D. joins Regen Med C/SAB

April 28, 2021

FDA Enforcement of Regenerative Medicine Products

April 22, 2021

Severe OA, Intra-Osseous Injections, ESSKA Congress

April 16, 2021

Platelets. Spin Optimization. Real World Study.

April 5, 2021

Using Real World Evidence to Compare Common Orthobiologic Clinical Options

March 31, 2021

PRP for Lower Back Pain

November 11, 2020

RegenMed Launches Regenerative Medicine Services of New York

June 16, 2020

“Good Actors” in Regenerative Medicine

June 16, 2020

Employee Monitoring for COVID-19 is Multi-faceted

June 10, 2020

10 Insights on Real World Evidence

June 9, 2020

The elective orthopedic surgery backlog and evidence-based regenerative medicine

June 3, 2020

How to meet COVID challenges to MDR compliance while producing strategic growth benefits

April 27, 2020

Align Post Marketing Surveillance and Post Marketing Clinical Follow-up with Product Lifecycle Management

March 26, 2020

COVID-19 Patient Stratification

March 26, 2020

COVID-19 Ongoing Core Workforce Monitoring

March 26, 2020

COVID-19 Patient Stratification Solution Proposed to Italian Ministry of Health

January 16, 2020

Show Me the (Right) Data

December 18, 2019

Regen Med Attendance at the 17th Annual IFATS Conference

December 5, 2019

Regen Med Attendance and Presentation at ASTAOR

November 11, 2019

Regen Med Attendance at the 5th International Symposium Intra-Articular Treatment (ISIAT)

November 6, 2019

inCytes™ Teaser

October 29, 2019

Regen Med Attendance at ICRS 2019 Summit in Vancouver

September 14, 2019

Medical Societies Adding Value To Their Members, and Advancing Their Mission

September 14, 2019

“Big Data” versus the “Right Data”

September 13, 2019

Building REGAIN™ With Gruppo San Donato

September 13, 2019

The Power of A Network of Affiliated RMCE’s

September 13, 2019

inCytes™: Making Data Work For the Physician

September 13, 2019

Better Online Ratings with Regular Follow-ups and Reports

June 27, 2019

Use of Real World Data and Evidence By Industry

June 27, 2019

Clinical and Financial Benefits of An RMCE

June 27, 2019

Regen Med Participation In An RMCE

June 27, 2019

Better Hip OA Outcomes Through E-Patient Monitoring and Reporting

June 27, 2019

FDA HCT/P Guidelines: Understanding and Adherence

June 27, 2019

Real World Evidence

January 27, 2023

RegenMed January 2023 Newsletter – Client Activities

January 26, 2023

Full Circle Interview: Dr. Grant Pagdin, MD

November 1, 2022

Comparing Long-Term Outcomes Across Varying Grades of Knee Osteoarthritis – A Real-World Cohort Study

September 8, 2022

The Value of Real-World Studies For Medical Societies and Foundations

August 30, 2022

KnowledgeBase: Study

August 30, 2022

KnowledgeBase: Circles

February 1, 2022

REAL-WORLD DATA: OWNERSHIP, CONTROL AND GENERATING VALUE

December 30, 2021

Supporting Healthcare Practitioners, Collaboration and Evidence

December 20, 2021

Ardent Animal Health, LLC Prepares Circles for Leading Animal Clinical Registry in 2022

December 7, 2021

First State Spine Uses Circles for Reimbursement

November 10, 2021

Opinion: American Medical Society for Sports Medicine Position

November 2, 2021

Plasmaconcept AG Prepares Circles for 2022 Post-Market Surveillance Strategy

October 28, 2021

The Role of Real-World Evidence in Medical Product Distribution

October 26, 2021

The Rising Role of Real-World Data and Real-World Evidence in Healthcare

October 6, 2021

Circles Chosen for Stem Cell-Enriched Lipofilling Patient Registry in Europe

September 7, 2021

Introducing Regenerative Medicine Services of France

July 28, 2021

Multinational Comparison of SVF, PRP and BMAC in MSK

July 14, 2021

PRP vs. Adipose in Knee OA, Argentina

June 30, 2021

CELLS Webinar: Intraosseous PRP for Knee OA

June 23, 2021

BMA in Sports Medicine: An Evidence-based Approach in NYC

June 16, 2021

New Webinar Series: PRP & BMAC

June 9, 2021

Improving Patient Engagement through Competition

May 19, 2021

Hyaluronic Acid v. HA+Autologous PRP For Knee OA

May 12, 2021

StemMedical’s Regenerative Aesthetics Registry

May 5, 2021

Kenneth R. Zaslav, M.D. joins Regen Med C/SAB

April 28, 2021

FDA Enforcement of Regenerative Medicine Products

April 22, 2021

Severe OA, Intra-Osseous Injections, ESSKA Congress

April 16, 2021

Platelets. Spin Optimization. Real World Study.

April 5, 2021

Using Real World Evidence to Compare Common Orthobiologic Clinical Options

March 31, 2021

PRP for Lower Back Pain

November 11, 2020

RegenMed Launches Regenerative Medicine Services of New York

June 16, 2020

“Good Actors” in Regenerative Medicine

June 16, 2020

Employee Monitoring for COVID-19 is Multi-faceted

June 10, 2020

10 Insights on Real World Evidence

June 9, 2020

The elective orthopedic surgery backlog and evidence-based regenerative medicine

April 27, 2020

Align Post Marketing Surveillance and Post Marketing Clinical Follow-up with Product Lifecycle Management

March 26, 2020

COVID-19 Patient Stratification

March 26, 2020

COVID-19 Ongoing Core Workforce Monitoring

March 26, 2020

COVID-19 Patient Stratification Solution Proposed to Italian Ministry of Health

January 16, 2020

Show Me the (Right) Data

December 18, 2019

Regen Med Attendance at the 17th Annual IFATS Conference

December 5, 2019

Regen Med Attendance and Presentation at ASTAOR

November 11, 2019

Regen Med Attendance at the 5th International Symposium Intra-Articular Treatment (ISIAT)

November 6, 2019

inCytes™ Teaser

October 29, 2019

Regen Med Attendance at ICRS 2019 Summit in Vancouver

September 14, 2019

Medical Societies Adding Value To Their Members, and Advancing Their Mission

September 14, 2019

“Big Data” versus the “Right Data”

September 13, 2019

Building REGAIN™ With Gruppo San Donato

September 13, 2019

The Power of A Network of Affiliated RMCE’s

September 13, 2019

inCytes™: Making Data Work For the Physician

September 13, 2019

Better Online Ratings with Regular Follow-ups and Reports

June 27, 2019

Use of Real World Data and Evidence By Industry

June 27, 2019

Clinical and Financial Benefits of An RMCE

June 27, 2019

Regen Med Participation In An RMCE

June 27, 2019

Better Hip OA Outcomes Through E-Patient Monitoring and Reporting

June 27, 2019

FDA HCT/P Guidelines: Understanding and Adherence

June 27, 2019

Real World Evidence

Follow usContact usSubscribeget started